Harvard Business Review recently released its annual ranking of the 100 “Best-Performing CEOs in the World”—and the list includes five CEOs in the American Healthcare Industry.

To create the ranking, HBR took into account financial returns over the CEOs’ tenure as well as the company’s rating on environmental, social, and governance (ESG) issues. HBR excludes CEOs with less than two years tenure.

For this year’s list, HBR made ESG account for a greater share of each CEO’s score than in years past, increasing its weight from 20% to 30%. According to HBR, the change in weighting led Amazon CEO Jeff Bezos, who’s made the list every year since 2014, to fall off the list in this edition, given Amazon’s relatively low ESG scores.

HBR noted that women are underrepresented on the list, making up just four entries on the 100-person list, up from three entries last year.

The American Healthcare CEOs who made the list include:

  1. Michael Mussallem, Edwards Lifesciences, Medical equipment
  2. Michael Mahoney, Boston Scientific, Manufacturer of medical devices
  3. Olivier Filliol, MettlerToledo, Scales and analytical instrumentation
  4. Marc Casper, Thermo Fisher Scientific, Biotechnology product development company
  5. Leonard Schleifer, Regeneron Pharmaceuticals, Biotechnology company

The complete article can be seen at:

https://hbr.org/2019/11/the-ceo-100-2019-edition#the-ceo-life-cycle